tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Cullinan Management (CGEM)
NASDAQ:CGEM
US Market
CGEM
Cullinan Management
Stock Analysis
Analyst Forecasts
News & Insights
Technical Analysis
Options
Chart
Earnings
Dividends
Ownership
Financials
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding CGEM?
Track your performance easily
Link Broker

Cullinan Management (CGEM) Stock News & Sentiment

186 Followers
Cullinan Therapeutics Announces Q3 2024 Progress and Outlook
Premium
Company Announcements
Cullinan Therapeutics Announces Q3 2024 Progress and Outlook
6d ago
CGEM
Cullinan Management Advances SLE Treatment with FDA Trial
Premium
Company Announcements
Cullinan Management Advances SLE Treatment with FDA Trial
1M ago
8K
CGEM
Cullinan Management Advances SLE Treatment with CLN-978 Trial
Premium
Company Announcements
Cullinan Management Advances SLE Treatment with CLN-978 Trial
2M ago
8K
CGEM
3 Best Stocks to Buy Now, 9/17/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 9/17/2024, According to Top Analysts 
2M ago
BMRN
CGEM
Cullinan Management’s Zipalertinib Shows Lung Cancer Trial Promise
Premium
Company Announcements
Cullinan Management’s Zipalertinib Shows Lung Cancer Trial Promise
6M ago
8K
CGEM
Cullinan Management Welcomes David Meek to Board of Directors
Premium
Company Announcements
Cullinan Management Welcomes David Meek to Board of Directors
7M ago
8K
CGEM
Investor Sentiment Swings in Favor of Cullinan Therapeutics (NASDAQ:CGEM)
Premium
Market News
Investor Sentiment Swings in Favor of Cullinan Therapeutics (NASDAQ:CGEM)
7M ago
CGEM
More CGEM News >

CGEM News on the Web

Cullinan Therapeutics Announces Q3 2024 Progress and Outlook
TipRanks News
Neutral
Promising Developments in Cullinan Management’s CLN-978 TCE for Autoimmune Diseases Drive Buy Rating
TipRanks News
Bullish
Cullinan Therapeutics: Promising Developments and Strategic Growth in Autoimmune Therapies
TipRanks News
Bullish
Promising Developments and Investment Potential in Cullinan Management: Edward White’s Buy Rating and $28 Price Target
TipRanks News
Bullish
Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients with Moderate to Severe Systemic Lupus Erythematosus
Yahoo Finance
Neutral
Cullinan Therapeutics Receives Approval to Initiate its Global Phase 1 Clinical Trial of CLN-978 for the Treatment of Systemic Lupus Erythematosus
Yahoo Finance
Neutral
Cullinan Therapeutics Announces Submission of Investigational New Drug Application to U.S. Food and Drug Administration for CLN-978 to Treat Systemic Lupus Erythematosus
Yahoo Finance
Neutral
Buy Rating Affirmed for Cullinan Management on Zipalertinib’s Market Potential and Efficient Clinical Advancement
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
CGEM
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average63%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CGEM’s Media Buzz Sentiment?
1 articles about CGEM were published this week. In an average week, 1 articles are published.
    What is CGEM’s weekly average amount of articles?
    In an average week, 1 articles about CGEM are published.
      What is CGEM’s News Sentiment?
      50% of articles about CGEM were positive this week, compared to its sector average of 63%.
        Healthcare Stocks that are Trending in the News
        SRRKScholar Rock Holding
        REPLReplimune Group
        GMEDGlobus Medical
        DBCCFDecibel Cannabis Company
        STXShield Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing